Ursula Nollenberger, product line director and Kevin Ehlert, segment manager, Trelleborg Healthcare & Medical discuss the necessary steps to launching a succesful drug/device combination product.
Anil Kumar Busimi - senior global product manager for SCHOTT iQ Platform at SCHOTT, explores how innovation in packaging is giving patients more options to administer medication from home.
Vanessa Fachada Oliveira, pharmacovigilance manager & EU QPPV at Arriello, highlights key areas of focus for marketing authorisation holders to achieve an effective audit of their pharmacovigilance systems.
Abi Pesun, director at Almac ONE explains how a shift towards unified supply chain management can accelerate timelines and help mitigate risk for clinical trials during Covid-19.
In this Perspective on Pharma featureJung Doh, market development scientist at Beckman Coulter Life Sciences, explains how they entered the pharmaceutical industry after an unexpected opportunity arose.
EPM speaks to Alex Guite, vice president of Services and Alliances at World Courier about the impact Covid-19 has had on the clinical trials sector and how a direct-to-patient approach can help trials continue.
Nick Pike, chief revenue officer at Vizibl discusses why pharmaceutical companies aren't only interested in the financial benefits when it comes to collaboration.
David Knight, partner and Joshua Marshall, senior associate at Fieldfisher discuss the implications the Covid-19 Technology Access Pool is having on innovation in pharma.
European Pharmaceutical Manufacturer editor Reece Armstrong looks at the issue of diversity in clinical trials and how medicines aren't developed with every patient in mind.
